Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +49.94%
#3 Velvet Velvet +41.51%
#4 Black Phoenix Black Phoenix +34.92%
#5 Palladium Network Palladium Network +21.70%
#6 DoubleZero DoubleZero +20.39%
#7 Akedo Akedo +19.80%
#8 Fake World Assets Fake World Assets +19.72%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.14%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.99%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPHW
Rank in Stocks #39800
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical... Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.
Share Price
$0.003
Last synced: 2025-12-12
Market Cap
$343.91K
Change (1 day)
-16.67%
Change (1 year)
-90.23%
Country
US
Trade Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Category

Healthcare
Stock price history for Reviva Pharmaceuticals Holdings, Inc. (RVPHW)
Highest end of day price: $0.01 on 2025-12-01

Lowest end of day price: $0.33 on 2018-10-01
Stock price history of Reviva Pharmaceuticals Holdings, Inc. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 305.88%
2025 -96.70%
2024 -75.67%
2023 0.82%
2022 134.68%
2021 -39.09%
2020 167.36%
2019 -15.00%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE